Published in J Cancer on November 26, 2016
Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles. Philos Trans R Soc Lond B Biol Sci (2018) 0.80
Obesity and p16(INK4A) Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol (2017) 0.75
The Linkage between Breast Cancer, Hypoxia, and Adipose Tissue. Front Oncol (2017) 0.75
Prenatal Exposure to Lipopolysaccharide Induces PTX3 Expression and Results in Obesity in Mouse Offspring. Inflammation (2017) 0.75
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Leptin and the regulation of body weight in mammals. Nature (1998) 14.84
Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 11.94
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol (2008) 8.43
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
Understanding adipocyte differentiation. Physiol Rev (1998) 6.84
Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr (2004) 6.31
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 6.15
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab (2001) 5.76
Oxyradicals and DNA damage. Carcinogenesis (2000) 4.87
Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol (2011) 4.72
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol (2002) 4.55
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48
A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol (2005) 3.98
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62
IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J (2003) 3.37
Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev (2009) 3.25
Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol (2009) 3.00
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract (2004) 2.95
Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr (2008) 2.73
The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72
Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm (2006) 2.72
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab (2003) 2.71
Adiponectin: mechanistic insights and clinical implications. Diabetologia (2012) 2.71
Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc (2001) 2.54
Obesity as a major risk factor for cancer. J Obes (2013) 2.26
Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res (2007) 2.25
The obese healthy paradox: is inflammation the answer? Biochem J (2010) 2.14
Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab (2005) 1.87
Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol (2001) 1.86
Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst (2002) 1.85
Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta (2013) 1.85
Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J (2009) 1.73
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res (2008) 1.71
Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc (2009) 1.71
Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res (2013) 1.65
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta (2013) 1.60
Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin (2008) 1.60
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene (2008) 1.59
The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm (2010) 1.59
Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell (2014) 1.53
Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol (2014) 1.51
Obesity, inflammation and the immune system. Proc Nutr Soc (2012) 1.47
Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab (2006) 1.47
IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res (2001) 1.46
Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem (2003) 1.45
Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) (2012) 1.44
Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun (2005) 1.42
White adipose tissue as endocrine organ and its role in obesity. Arch Med Res (2008) 1.42
Endocrinology of adipose tissue - an update. Horm Metab Res (2007) 1.41
Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer (2006) 1.41
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. PLoS One (2015) 1.40
The development and endocrine functions of adipose tissue. Mol Cell Endocrinol (2009) 1.37
Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity. Cell Metab (2013) 1.27
Interleukin-6 and insulin resistance. Vitam Horm (2009) 1.27
Adipocyte and adipogenesis. Eur J Cell Biol (2013) 1.27
Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab (2004) 1.25
Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism (2014) 1.25
New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int (2014) 1.24
TNF-alpha and obesity. Curr Dir Autoimmun (2010) 1.24
Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci (2012) 1.23
Adipokines in health and disease. Trends Pharmacol Sci (2015) 1.19
Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol (2014) 1.19
Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem (2008) 1.18
Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann N Y Acad Sci (2012) 1.17
Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest (2014) 1.15
Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev (2013) 1.14
Adipose tissue-derived progenitor cells and cancer. World J Stem Cells (2010) 1.12
Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol (2011) 1.11
Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ Res (2012) 1.11
The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis. Health Technol Assess (2015) 1.11
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol (2014) 1.11
Clinical relevance of adipokines. Diabetes Metab J (2012) 1.10
Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab (2013) 1.10
Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity. Annu Rev Nutr (2014) 1.09
Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J Hepatol (2007) 1.09
Obesity and cancer: local and systemic mechanisms. Annu Rev Med (2015) 1.09
Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz) (2013) 1.08
Adipose tissue and adipocyte dysregulation. Diabetes Metab (2013) 1.07
Oxygen free radicals and the systemic inflammatory response. IUBMB Life (2004) 1.07
20 years of leptin: human disorders of leptin action. J Endocrinol (2014) 1.07
Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells (2014) 1.05
Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer (2015) 1.05
Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun Signal (2009) 1.04
The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation. Eur J Immunol (2015) 1.04
Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J (2014) 1.03
Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1ß toxicity through AdipoR1. Int J Biochem Cell Biol (2013) 1.01
Immune cell crosstalk in obesity: a key role for costimulation? Diabetes (2014) 1.00
Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Biochimie (2012) 1.00
Adipose Tissue as an Endocrine Organ: An Update on Pro-inflammatory and Anti-inflammatory Microenvironment. Prague Med Rep (2015) 0.99
Cold-induced expression of the VEGF gene in brown adipose tissue is independent of thermogenic oxygen consumption. FEBS Lett (2005) 0.99
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation (2014) 0.98
20 years of leptin: connecting leptin signaling to biological function. J Endocrinol (2014) 0.98
Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat (2007) 0.98